Oncolytic viruses work by injecting genetic material into cancer cells, which modify them and make them visible to the immune system, which moves into destroy the tumour. The issue with Imlygic is ...

Backed by a $2 million grant, University of New Mexico Comprehensive Cancer Center professor Eric Bartee's research raises the hope that certain viruses can actually trigger an immune response to ...

A new study led by scientists at the University of Oxford has revealed something surprising: a common virus carried by more ...

Even well-known proteins can surprise us; some go beyond their recognised roles, stepping in to awaken latent viruses and ...

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments. Melanoma is a ...

The first documented use of NDV for human cancer therapy was reported in 1964 by Wheelock and Dingle, where a patient with acute myelogenous leukemia was serially inoculated with multiple viruses ...

Bristol-Myers Squibb has acquired rights to an “armed virus” targeting cancer from UK biotech, PsiOxus Therapeutics, worth more than $900 million if the project is successful. BMS will pay ...

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

Immorta Bio SenoVax™ Senolytic Cancer Immunotherapy Boosts Multiple Arms of the Immune System "It is widely known that as people age there is a progressive increase in the incidence of cancers ...

NK cells are believed to play a fundamental role in the ability of the body to fight cancer and viruses. Studies have shown that higher numbers of NK cells infiltrating tumors results in longer ...